2021 Q1 Form 10-Q Financial Statement

#000143774921012533 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $139.0K $114.0K
YoY Change 21.93% 4.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.230M $3.980M
YoY Change -18.84% 36.3%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $103.0K $79.00K
YoY Change 30.38% 19.7%
% of Gross Profit
Operating Expenses $3.340M $4.060M
YoY Change -17.73% 35.79%
Operating Profit -$3.197M -$3.942M
YoY Change -18.9% 36.83%
Interest Expense $2.542M $3.572M
YoY Change -28.84% -15.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.739M -$19.89M
YoY Change -71.14% 173.95%
Income Tax $2.000K $2.000K
% Of Pretax Income
Net Earnings -$5.944M -$20.51M
YoY Change -71.02% 182.56%
Net Earnings / Revenue -4276.26% -17994.74%
Basic Earnings Per Share -$0.16
Diluted Earnings Per Share -$157.0K -$659.3K
COMMON SHARES
Basic Shares Outstanding 37.83M 34.39M
Diluted Shares Outstanding 37.83K 31.11K

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.70M $10.50M
YoY Change 78.1% -35.19%
Cash & Equivalents $18.67M $10.52M
Short-Term Investments
Other Short-Term Assets $800.0K $600.0K
YoY Change 33.33% -14.29%
Inventory
Prepaid Expenses
Receivables $18.00K $76.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.51M $11.23M
YoY Change 73.77% -33.75%
LONG-TERM ASSETS
Property, Plant & Equipment $53.70M $51.63M
YoY Change 4.03% 10.02%
Goodwill $3.813M $3.813M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $1.288M $1.028M
YoY Change 25.29%
Other Assets $4.936M $4.378M
YoY Change 12.75% 3.08%
Total Long-Term Assets $70.04M $62.85M
YoY Change 11.45% 10.29%
TOTAL ASSETS
Total Short-Term Assets $19.51M $11.23M
Total Long-Term Assets $70.04M $62.85M
Total Assets $89.55M $74.07M
YoY Change 20.9% 0.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $177.0K $961.0K
YoY Change -81.58% -7.42%
Accrued Expenses $2.066M $975.0K
YoY Change 111.9% -7.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $47.00K $20.00K
YoY Change 135.0% -66.67%
Total Short-Term Liabilities $2.316M $4.548M
YoY Change -49.08% 45.96%
LONG-TERM LIABILITIES
Long-Term Debt $78.92M $72.40M
YoY Change 9.01% -47.05%
Other Long-Term Liabilities $21.40M $3.000K
YoY Change 713233.33% -99.98%
Total Long-Term Liabilities $78.92M $72.40M
YoY Change 9.01% -47.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.316M $4.548M
Total Long-Term Liabilities $78.92M $72.40M
Total Liabilities $102.6M $93.76M
YoY Change 9.43% -39.65%
SHAREHOLDERS EQUITY
Retained Earnings -$545.4M -$522.1M
YoY Change 4.45% 8.93%
Common Stock $382.0K $347.0K
YoY Change 10.09% 33.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.05M -$19.69M
YoY Change
Total Liabilities & Shareholders Equity $89.55M $74.07M
YoY Change 20.9% 0.19%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$5.944M -$20.51M
YoY Change -71.02% 182.56%
Depreciation, Depletion And Amortization $103.0K $79.00K
YoY Change 30.38% 19.7%
Cash From Operating Activities -$2.823M -$4.379M
YoY Change -35.53% 8.53%
INVESTING ACTIVITIES
Capital Expenditures $513.0K $3.453M
YoY Change -85.14% 1992.73%
Acquisitions
YoY Change
Other Investing Activities -$140.0K -$1.240M
YoY Change -88.71%
Cash From Investing Activities -$650.0K -$4.693M
YoY Change -86.15% 2744.24%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net $14.87M $3.923M
YoY Change 278.97% -50.29%
Debt Paid & Issued, Net $13.00K $15.00K
YoY Change -13.33% 7.14%
Cash From Financing Activities $14.85M $3.908M
YoY Change 280.09% -50.39%
NET CHANGE
Cash From Operating Activities -$2.823M -$4.379M
Cash From Investing Activities -$650.0K -$4.693M
Cash From Financing Activities $14.85M $3.908M
Net Change In Cash $11.38M -$5.164M
YoY Change -320.39% -240.44%
FREE CASH FLOW
Cash From Operating Activities -$2.823M -$4.379M
Capital Expenditures $513.0K $3.453M
Free Cash Flow -$3.336M -$7.832M
YoY Change -57.41% 86.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38787264
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7531
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7531
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7531
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7531
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38342952
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38342952
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36902361
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36902361
CY2021Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P29Y
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7531
CY2021Q1 us-gaap Revenues
Revenues
139000 USD
CY2020Q1 us-gaap Revenues
Revenues
114000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3233000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3977000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
103000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
79000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
3336000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
4056000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3197000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3942000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
19507000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8036000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53704000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53481000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37834
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31113
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18671000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7290000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
818000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
691000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
2542000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
3572000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
22000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12394000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5739000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-19886000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-203000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-626000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5944000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20514000 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2021Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
3000000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
3000000 USD
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
1288000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1354000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
3813000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
3813000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3301000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4936000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4664000 USD
CY2021Q1 us-gaap Assets
Assets
89549000 USD
CY2020Q4 us-gaap Assets
Assets
74363000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
177000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
548000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2066000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
674000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
47000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
51000 USD
CY2021Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1847000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2316000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3135000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78921000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78596000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89549000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74363000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5944000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20514000 USD
CY2021Q1 cdzi Depreciation Depletion And Amortization Excluding Amortization Of Right Of Use Assets
DepreciationDepletionAndAmortizationExcludingAmortizationOfRightOfUseAssets
103000 USD
CY2020Q1 cdzi Depreciation Depletion And Amortization Excluding Amortization Of Right Of Use Assets
DepreciationDepletionAndAmortizationExcludingAmortizationOfRightOfUseAssets
79000 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
453000 USD
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
351000 USD
CY2021Q1 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
17579000 USD
CY2020Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
17183000 USD
CY2021Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3035000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q1 us-gaap Liabilities
Liabilities
102601000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
99664000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
382000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
368000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
531923000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
513744000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-545358000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-539414000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-13052000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2021Q1 cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
1792000 USD
CY2020Q1 cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
1854000 USD
CY2021Q1 cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
390000 USD
CY2020Q1 cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
347000 USD
CY2021Q1 cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-203000 USD
CY2020Q1 cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-626000 USD
CY2021Q1 cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-0 USD
CY2020Q1 cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-12396000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
147000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1250000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
561000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
127000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
246000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
272000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
271000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-188000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
738000 USD
CY2021Q1 cdzi Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-255000 USD
CY2020Q1 cdzi Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1396000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1523000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2823000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4379000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
513000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3453000 USD
CY2021Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
137000 USD
CY2020Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1240000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-650000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4693000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14867000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3923000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14854000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3908000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11381000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5164000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18805000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10652000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25301000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
148000 USD
CY2021Q1 cdzi Current Period Reclassification Adjustment
CurrentPeriodReclassificationAdjustment
3179000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14866000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5944000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-13052000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
38900000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1251000 USD
CY2020Q1 cdzi Current Period Reclassification Adjustment
CurrentPeriodReclassificationAdjustment
-865000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20514000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-19687000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5900000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20500000 USD
CY2021Q1 cdzi Working Capital
WorkingCapital
17200000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2800000 USD
CY2021Q1 cdzi Required Payment To Acquire Property Available For Purchase Due End Of Fiscal Year
RequiredPaymentToAcquirePropertyAvailableForPurchaseDueEndOfFiscalYear
19000000 USD
CY2021Q1 cdzi Percentage Of Future Quarterly Interest Payments
PercentageOfFutureQuarterlyInterestPayments
0.25 pure
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
373000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18671000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7290000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10518000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18805000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7424000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10652000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
115000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
146000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1250000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1200000 USD
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3442000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1679000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3300000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
92000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
323000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
321000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
321000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
321000 USD
CY2021Q1 cdzi Lessee Operating Lease Liability Payments Due After Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFour
7692000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8978000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5917000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3061000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10 pure
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-573000 USD
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7531

Files In Submission

Name View Source Status
0001437749-21-012533-index-headers.html Edgar Link pending
0001437749-21-012533-index.html Edgar Link pending
0001437749-21-012533.txt Edgar Link pending
0001437749-21-012533-xbrl.zip Edgar Link pending
cdzi-20210331.xsd Edgar Link pending
cdzi-20210331_cal.xml Edgar Link unprocessable
cdzi-20210331_def.xml Edgar Link unprocessable
cdzi-20210331_lab.xml Edgar Link unprocessable
cdzi-20210331_pre.xml Edgar Link unprocessable
cdzi20210331_10q.htm Edgar Link pending
cdzi20210331_10q_htm.xml Edgar Link completed
ex_250299.htm Edgar Link pending
ex_250301.htm Edgar Link pending
ex_250310.htm Edgar Link pending
ex_250311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending